PharmEasy Investor Marks Down Its Valuation To $456 Mn

PharmEasy’s investor Janus Henderson noted that his stake of 12.9 Mn shares is now valued at just over $0.76 Mn down from an initial investment of $9.4 Mn

The development comes after the company secured over $216 Mn in fresh capital earlier this year

The company saw its consolidated net loss halve to INR 2,531.1 Cr in the financial year 2023-24 (FY24)

The valuation of online pharmacy PharmEasy has plummeted to around $456 Mn, a drastic decline of 92% from its previous peak valuation of $5.6 Bn. This also marks another 18.57% valuation cut from the last fundraising in April, which valued the company at around $560 Mn . 

This significant drop was reported by TechCrunch first, citing PharmEasy’s investor Janus Henderson, who noted that his stake of 12.9 Mn shares is now valued at…